0001209191-21-025759.txt : 20210406 0001209191-21-025759.hdr.sgml : 20210406 20210406200240 ACCESSION NUMBER: 0001209191-21-025759 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210401 FILED AS OF DATE: 20210406 DATE AS OF CHANGE: 20210406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUGGENHIME ANDREW CENTRAL INDEX KEY: 0001230724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39323 FILM NUMBER: 21810369 MAIL ADDRESS: STREET 1: 3061 ZANKER RD CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxcyte, Inc. CENTRAL INDEX KEY: 0001649094 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464233385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 353 HATCH DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-837-0111 MAIL ADDRESS: STREET 1: 353 HATCH DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: SutroVax, Inc. DATE OF NAME CHANGE: 20150724 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-01 0 0001649094 Vaxcyte, Inc. PCVX 0001230724 GUGGENHIME ANDREW C/O VAXCYTE, INC. 353 HATCH DRIVE FOSTER CITY CA 94404 0 1 0 0 President and CFO Stock Option (right to buy) 20.93 2021-04-01 4 A 0 145000 0.00 A 2031-03-31 Common Stock 145000 145000 D 1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter. /s/ Winston Macaraeg, Attorney-in-Fact 2021-04-06